China Clears Its First Microarray Platform for in Vitro Diagnostics to Accelerate Personalized Medicine

This is an interesting article about SFDA's approval in China for the first Microarray Platform for in Vitro Diagnostics. It's not only a first for the Platform but also moves closer to truly personalised medicine. Affymetrix, Inc views this registration as a significant start to their growth within Asia especially when you consider that the molecular diagnostic market in China is the fastest growing in the world .

Share: